Celgene Cash on Hand 2006-2018 | CELG

Celgene cash on hand from 2006 to 2018. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Celgene cash on hand for the quarter ending December 31, 2018 was $6.042B, a 49.83% decline year-over-year.
  • Celgene cash on hand for 2018 was $6.042B, a 49.83% decline from 2017.
  • Celgene cash on hand for 2017 was $12.042B, a 51.09% increase from 2016.
  • Celgene cash on hand for 2016 was $7.97B, a 21.64% increase from 2015.
Celgene Annual Cash on Hand
(Millions of US $)
2018 $6,042
2017 $12,042
2016 $7,970
2015 $6,552
2014 $7,547
2013 $5,687
2012 $3,900
2011 $2,648
2010 $2,601
2009 $2,997
2008 $2,222
2007 $2,739
2006 $1,982
2005 $724
Celgene Quarterly Cash on Hand
(Millions of US $)
Q4 2018 $6,042
Q3 2018 $4,378
Q2 2018 $3,410
Q1 2018 $4,740
Q4 2017 $12,042
Q3 2017 $11,759
Q2 2017 $10,140
Q1 2017 $8,861
Q4 2016 $7,970
Q3 2016 $6,869
Q2 2016 $6,404
Q1 2016 $5,707
Q4 2015 $6,552
Q3 2015 $7,506
Q2 2015 $7,492
Q1 2015 $7,314
Q4 2014 $7,547
Q3 2014 $6,861
Q2 2014 $6,213
Q1 2014 $5,110
Q4 2013 $5,687
Q3 2013 $5,847
Q2 2013 $4,081
Q1 2013 $3,521
Q4 2012 $3,900
Q3 2012 $3,833
Q2 2012 $2,562
Q1 2012 $2,269
Q4 2011 $2,648
Q3 2011 $2,579
Q2 2011 $2,789
Q1 2011 $2,431
Q4 2010 $2,601
Q3 2010 $3,530
Q2 2010 $3,145
Q1 2010 $2,954
Q4 2009 $2,997
Q3 2009 $2,764
Q2 2009 $2,498
Q1 2009 $2,393
Q4 2008 $2,222
Q3 2008 $2,454
Q2 2008 $2,257
Q1 2008 $2,026
Q4 2007 $2,739
Q3 2007 $2,530
Q2 2007 $2,322
Q1 2007 $2,115
Q4 2006 $1,982
Q3 2006 $872
Q2 2006 $758
Q1 2006 $773
Q4 2005 $724
Q3 2005 $746
Q2 2005 $724
Q1 2005 $701
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $66.241B $15.281B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.392B 12.66
Gilead Sciences (GILD) United States $80.676B 10.27
Illumina (ILMN) United States $46.818B 55.72
Biogen (BIIB) United States $44.688B 8.66
Vertex Pharmaceuticals (VRTX) United States $42.687B 57.18
Regeneron Pharmaceuticals (REGN) United States $37.478B 17.41
Alexion Pharmaceuticals (ALXN) United States $28.137B 17.44
Incyte (INCY) United States $15.924B 148.64
BioMarin Pharmaceutical (BMRN) United States $14.689B 0.00
Exact Sciences (EXAS) United States $11.546B 0.00
Seattle Genetics (SGEN) United States $11.396B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
Alnylam Pharmaceuticals (ALNY) United States $9.024B 0.00
QIAGEN (QGEN) Netherlands $8.689B 28.75
Sarepta Therapeutics (SRPT) United States $8.465B 0.00
Moderna (MRNA) United States $7.732B 0.00
Bluebird Bio (BLUE) United States $7.660B 0.00
BeiGene (BGNE) Cayman Islands $7.227B 0.00
Bio-Techne Corp (TECH) United States $7.127B 48.02
Exelixis (EXEL) United States $6.437B 14.94
Guardant Health (GH) United States $6.248B 0.00
Galapagos (GLPG) Belgium $5.840B 0.00
Amarin (AMRN) Ireland $5.703B 0.00
Alkermes (ALKS) Ireland $5.202B 0.00
Array BioPharma (ARRY) United States $4.877B 0.00
Horizon Pharma Public (HZNP) Ireland $4.537B 13.44
Ascendis Pharma (ASND) Denmark $4.502B 0.00
Spark Therapeutics (ONCE) United States $4.203B 0.00
China Biologic Products (CBPO) China $3.826B 23.70
ARGENX SE-ADR (ARGX) Netherlands $3.700B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.355B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.318B 0.00
Blueprint Medicines (BPMC) United States $3.251B 0.00
Global Blood Therapeutics (GBT) United States $3.187B 0.00
Immunomedics (IMMU) United States $3.171B 0.00
Allogene Therapeutics (ALLO) United States $3.105B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.092B 0.00
Amicus Therapeutics (FOLD) United States $2.879B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.665B 0.00
Emergent Biosolutions (EBS) United States $2.651B 22.05
Intercept Pharmaceuticals (ICPT) United States $2.647B 0.00
Denali Therapeutics (DNLI) United States $2.497B 0.00
Akcea Therapeutics (AKCA) United States $2.457B 0.00
Ligand Pharmaceuticals (LGND) United States $2.451B 18.30
Repligen (RGEN) United States $2.381B 73.24
Halozyme Therapeutics (HALO) United States $2.377B 0.00
Myriad Genetics (MYGN) United States $2.348B 23.92
Reata Pharmaceuticals (RETA) United States $2.337B 0.00
Insmed (INSM) United States $2.286B 0.00
Genomic Health (GHDX) United States $2.266B 57.92
Arena Pharmaceuticals (ARNA) United States $2.222B 0.00
Mirati Therapeutics (MRTX) United States $2.195B 0.00
Acceleron Pharma (XLRN) United States $2.132B 0.00
UniQure (QURE) Netherlands $2.055B 0.00
Medicines (MDCO) United States $2.033B 0.00
REGENXBIO (RGNX) United States $2.003B 20.81
AnaptysBio (ANAB) United States $1.982B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.905B 0.00
MyoKardia (MYOK) United States $1.890B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.854B 0.00
NeoGenomics (NEO) United States $1.851B 150.54
Zai Lab Unsponsored ADR (ZLAB) China $1.666B 0.00
Audentes Therapeutics (BOLD) United States $1.645B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.589B 0.00
Allakos (ALLK) United States $1.552B 0.00
Atara Biotherapeutics (ATRA) United States $1.504B 0.00
Alector (ALEC) United States $1.483B 0.00
Rubius Therapeutics (RUBY) United States $1.416B 0.00
Myovant Sciences (MYOV) United Kingdom $1.367B 0.00
Innoviva (INVA) United States $1.352B 3.72
Momenta Pharmaceuticals (MNTA) United States $1.349B 0.00
Lion Biotechnologies (IOVA) United States $1.329B 0.00
InflaRx (IFRX) Germany $1.313B 0.00
Cambrex (CBM) United States $1.277B 13.74
Aimmune Therapeutics (AIMT) United States $1.274B 0.00
Puma Biotechnology (PBYI) United States $1.265B 0.00
Editas Medicine (EDIT) United States $1.263B 0.00
Sangamo Therapeutics (SGMO) United States $1.197B 0.00
Apellis Pharmaceuticals (APLS) United States $1.178B 0.00
Epizyme (EPZM) United States $1.145B 0.00
Clovis Oncology (CLVS) United States $1.102B 0.00
Gossamer Bio (GOSS) United States $1.078B 0.00
Codexis (CDXS) United States $1.056B 0.00
NGM BIOPHARMACT (NGM) United States $1.040B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.033B 0.00
Coherus BioSciences (CHRS) United States $1.022B 0.00
Fate Therapeutics (FATE) United States $1.015B 0.00
Clementia Pharmaceuticals (CMTA) Canada $1.003B 0.00
Genfit SA (GNFT) France $0.941B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.939B 0.00
WAVE Life Sciences (WVE) Singapore $0.889B 0.00
RA PHARMCTL INC (RARX) United States $0.886B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.880B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.877B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.876B 35.40
Alder BioPharmaceuticals (ALDR) United States $0.875B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.874B 0.00
Eidos Therapeutics (EIDX) United States $0.861B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.841B 0.00
Retrophin (RTRX) United States $0.837B 0.00
Cellectis (CLLS) France $0.827B 0.00
ANI Pharmaceuticals (ANIP) United States $0.818B 14.97
Twist Bioscience (TWST) United States $0.797B 0.00
Athenex (ATNX) United States $0.755B 0.00
Intellia Therapeutics (NTLA) United States $0.737B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.722B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.717B 0.00
Cara Therapeutics (CARA) United States $0.715B 0.00
Vericel (VCEL) United States $0.712B 0.00
Principia Biopharma (PRNB) United States $0.692B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.674B 0.00
Intra-Cellular Therapies (ITCI) United States $0.671B 0.00
Arvinas (ARVN) United States $0.669B 0.00
G1 THERAPEUTICS (GTHX) United States $0.659B 0.00
Osiris Therapeutics (OSIR) United States $0.656B 0.00
Precision BioSciences (DTIL) United States $0.636B 0.00
MeiraGTx Holdings (MGTX) United States $0.622B 0.00
Viking Therapeutics (VKTX) United States $0.619B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.602B 0.00
ObsEva SA (OBSV) Switzerland $0.585B 0.00
Revance Therapeutics (RVNC) United States $0.583B 0.00
Stemline Therapeutics (STML) United States $0.572B 0.00
Heska (HSKA) United States $0.568B 50.97
Zealand Pharma (ZEAL) Denmark $0.563B 6.27
Kura Oncology (KURA) United States $0.562B 0.00
Synthorx (THOR) United States $0.557B 0.00
Acorda Therapeutics (ACOR) United States $0.552B 7.15
DBV Technologies (DBVT) France $0.533B 0.00
Mesoblast (MESO) Australia $0.517B 0.00
Magenta Therapeutics (MGTA) United States $0.509B 0.00
UROGEN PHARMA (URGN) United States $0.502B 0.00
Zymeworks (ZYME) Canada $0.496B 0.00
Axsome Therapeutics (AXSM) United States $0.496B 0.00
Arcus Biosciences (RCUS) United States $0.485B 0.00
AVROBIO (AVRO) United States $0.482B 0.00
Sorrento Therapeutics (SRNE) United States $0.476B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.462B 0.00
CytomX Therapeutics (CTMX) United States $0.457B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.451B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.449B 0.00
PDL BioPharma (PDLI) United States $0.443B 9.89
CYCLERION THERA (CYCN) United States $0.443B 0.00
Anika Therapeutics (ANIK) United States $0.443B 16.75
Krystal Biotech (KRYS) United States $0.441B 0.00
Cytokineticsorporated (CYTK) United States $0.440B 0.00
KALEIDO BIOSCI (KLDO) $0.439B 0.00
Scholar Rock Holding (SRRK) United States $0.439B 0.00
Five Prime Therapeutics (FPRX) United States $0.433B 0.00
Prothena (PRTA) Ireland $0.429B 0.00
MediciNova (MNOV) United States $0.415B 0.00
Dynavax Technologies (DVAX) United States $0.412B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.408B 0.00
Gritstone Oncology (GRTS) United States $0.406B 0.00
Replimune (REPL) United States $0.402B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.402B 0.00
Abeona Therapeutics (ABEO) United States $0.393B 0.00
Kezar Life Sciences (KZR) United States $0.382B 0.00
Senesco Technologies (ELOX) United States $0.381B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Albireo Pharma (ALBO) United States $0.370B 0.00
STEALTH BIOTHER (MITO) United States $0.366B 0.00
Inovio Pharmaceuticals (INO) United States $0.363B 0.00
Adverum Biotechnologies (ADVM) United States $0.357B 0.00
PHASEBIO PHARMA (PHAS) United States $0.345B 0.00
Merus (MRUS) Netherlands $0.345B 0.00
Agenus (AGEN) United States $0.341B 0.00
BeyondSpring (BYSI) United States $0.339B 0.00
Kindred Biosciences (KIN) United States $0.337B 0.00
UNITY Biotechnology (UBX) $0.336B 0.00
BioDelivery Sciences (BDSI) United States $0.332B 0.00
Geron (GERN) United States $0.324B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.319B 0.00
AC Immune SA (ACIU) Switzerland $0.319B 0.00
XBiotech (XBIT) United States $0.312B 0.00
Solid Biosciences (SLDB) United States $0.312B 0.00
Constellation Pharmaceuticals (CNST) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.306B 0.00
Kadmon Holdings (KDMN) United States $0.302B 0.00
MannKind (MNKD) United States $0.289B 0.00
Seres Therapeutics (MCRB) United States $0.281B 0.00
LogicBio Therapeutics (LOGC) United States $0.281B 0.00
Aduro Biotech (ADRO) United States $0.272B 0.00
Evelo Biosciences (EVLO) United States $0.261B 0.00
Kala Pharmaceuticals (KALA) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.258B 0.00
Enochian BioSciences (ENOB) United States $0.255B 0.00
Urovant Sciences (UROV) United States $0.253B 0.00
Kamada (KMDA) Israel $0.252B 11.38
Eiger BioPharmaceuticals (EIGR) United States $0.251B 0.00
Novavax (NVAX) United States $0.249B 0.00
ResTORbio (TORC) United States $0.247B 0.00
Sutro Biopharma (STRO) United States $0.245B 0.00
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
Protagonist Therapeutics (PTGX) United States $0.244B 0.00
Avid Bioservices (CDMO) United States $0.242B 0.00
Syros Pharmaceuticals (SYRS) United States $0.235B 0.00
Celcuity (CELC) United States $0.225B 0.00
Cerecor (CERC) United States $0.222B 0.00
Palatin Technologies (PTN) United States $0.221B 109.00
ChromaDex (CDXC) United States $0.220B 0.00
ADMA Biologics Inc (ADMA) United States $0.217B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.215B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.212B 0.00
OSMOTICA PHARM (OSMT) United States $0.208B 0.00
Celyad SA (CYAD) Belgium $0.208B 0.00
Intec Pharma (NTEC) Israel $0.205B 0.00
OvaScience (MLND) United States $0.205B 0.00
Athersys (ATHX) United States $0.204B 0.00
Gamida Cell (GMDA) Israel $0.203B 0.00
Spero Therapeutics (SPRO) United States $0.203B 0.00
Mersana Therapeutics (MRSN) United States $0.202B 0.00
Synlogic (SYBX) United States $0.202B 0.00
CorMedix Inc (CRMD) United States $0.201B 0.00
VBI Vaccines (VBIV) United States $0.200B 0.00
TOCAGEN INC (TOCA) United States $0.199B 0.00
Cel-Sci (CVM) United States $0.191B 0.00
Axovant Sciences (AXGT) United Kingdom $0.190B 0.00
Arbutus Biopharma (ABUS) Canada $0.189B 0.00
Pfenex (PFNX) United States $0.185B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.181B 0.00
BioTime (BTX) United States $0.179B 0.00
Cue Biopharma (CUE) United States $0.170B 0.00
Menlo Therapeutics (MNLO) United States $0.169B 0.00
Enzo Biochem (ENZ) United States $0.169B 0.00
Compugen (CGEN) Israel $0.169B 0.00
Verastem (VSTM) United States $0.165B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.157B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.153B 0.00
BioXcel Therapeutics (BTAI) United States $0.151B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.151B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.148B 0.00
Chiasma (CHMA) United States $0.143B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.143B 0.00
Anavex Life Sciences (AVXL) United States $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Trevena (TRVN) United States $0.139B 0.00
Allena Pharmaceuticals (ALNA) United States $0.137B 0.00
Eton Pharmaceuticals (ETON) United States $0.135B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.135B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.128B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.122B 0.00
VolitionRX (VNRX) Singapore $0.122B 0.00
Aptinyx (APTX) United States $0.121B 0.00
Provention Bio (PRVB) United States $0.118B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.114B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.113B 0.00
XOMA (XOMA) United States $0.110B 0.00
Neothetics (EVFM) United States $0.108B 0.00
Unum Therapeutics (UMRX) United States $0.107B 0.00
Cohbar (CWBR) United States $0.105B 0.00
Catalyst Biosciences (CBIO) United States $0.104B 0.00
Selecta Biosciences (SELB) United States $0.103B 0.00
INMUNE BIO INC (INMB) United States $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.099B 0.00
NantKwest (NK) United States $0.098B 0.00
Equillium (EQ) United States $0.095B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.094B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
Signal Genetics (MGEN) United States $0.088B 0.00
Cocrystal Pharma (COCP) United States $0.085B 90.00
Applied Genetic Technologies (AGTC) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Fortress Biotech (FBIO) United States $0.083B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.082B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.080B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.080B 0.00
Alcobra (ARCT) United States $0.080B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.079B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.077B 0.00
Eyenovia (EYEN) United States $0.076B 0.00
Mustang Bio (MBIO) United States $0.075B 0.00
Aptose Biosciences (APTO) Canada $0.074B 0.00
Orgenesis (ORGS) United States $0.074B 0.00
AEterna Zentaris (AEZS) United States $0.071B 17.24
OVID THERAPEUTC (OVID) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.068B 0.00
Cidara Therapeutics (CDTX) United States $0.067B 0.00
Idera Pharmaceuticals (IDRA) United States $0.067B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
Proteostasis Therapeutics (PTI) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.064B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Apricus Biosciences (SEEL) United States $0.062B 0.00
VTv Therapeutics (VTVT) United States $0.061B 0.00
Curis (CRIS) United States $0.060B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.060B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Evogene (EVGN) Israel $0.057B 0.00
ScPharmaceuticals (SCPH) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
HOTH THERAPEUTC (HOTH) United States $0.050B 0.00
Celldex Therapeutics (CLDX) United States $0.049B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
VistaGen Therapeutics (VTGN) United States $0.048B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.047B 0.00
AZURRX BIOPHARM (AZRX) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.045B 0.00
ANCHIANO THERAP (ANCN) Israel $0.044B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.044B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Celsion (CLSN) United States $0.044B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
Zosano Pharma (ZSAN) United States $0.042B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.041B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
VIVUS (VVUS) United States $0.039B 0.00
OncoSec Medical (ONCS) United States $0.038B 0.00
Arsanis (XFOR) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.034B 0.00
Moleculin Biotech (MBRX) United States $0.033B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Motif Bio Plc (MTFB) United States $0.032B 0.00
Sophiris Bio (SPHS) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Adial Pharmaceuticals (ADIL) United States $0.029B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
GTx (GTXI) United States $0.028B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.025B 0.00
Vical (VICL) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.025B 0.00
Oragenics (OGEN) United States $0.024B 0.00
Galena Biopharma (SLS) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
TRACON Pharmaceuticals (TCON) United States $0.022B 0.00
IMMURON LTD (IMRN) Australia $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Histogenics (HSGX) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
Advaxis (ADXS) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
BioPharmX (BPMX) United States $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Dare Bioscience (DARE) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 6.05
RestorGenex (DFFN) United States $0.011B 0.00
AmpliPhi Biosciences (APHB) United States $0.011B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
Proteon Therapeutics (PRTO) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Edge Therapeutics (PDSB) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.009B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00